MyBody-X approaches Vitamin D in daily life through multiple test modalities: blood biomarkers (25-hydroxyvitamin D), genetic variants in the VDR gene (e.g., rs2228570, rs1544410), and microbiome parameters that may indirectly affect vitamin D absorption. The evidence is mixed. Blood levels are well-validated and clinically relevant – deficiency (below 20 ng/ml) is linked to bone health, immune function, and mood. Genetics show only small effects: VDR SNPs explain less than 5% of vitamin D status variance. Supplementation based on a single SNP is not evidence-based. Microbiome tests do not directly measure vitamin D; links via bile acid and fat metabolism are mechanistic but insufficiently proven. MyBody-X should clearly communicate that blood testing remains the gold standard and that genetic risk scores are only adjunctive. In everyday life, adequate sun exposure (depending on skin type, latitude, season) is the primary source. Supplementation is recommended only for confirmed deficiency or risk groups (elderly, dark skin, limited sun). Combining blood values with lifestyle advice is sensible; genetic tests alone are insufficient for daily management. Safety note: Vitamin D is fat-soluble – long-term overdose (above 4000 IU/day) can cause hypercalcemia. MyBody-X should highlight these limits.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-b161fd4094b7a0dcc2c89eac